These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 218991)

  • 21. Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.
    Calmettes C; Moudktar MS; Milhaud G
    Biomedicine; 1977 Mar; 27(2):52-4. PubMed ID: 861349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for medullary carcinoma of the thyroid in families with Sipple's syndrome: evaluation of new stimulation tests.
    Telenius-Berg M; Almqvist S; Berg B; Hedner P; Ingemansson S; Tibblin S; Wasthed B
    Eur J Clin Invest; 1977 Feb; 7(1):7-16. PubMed ID: 402280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcitonin release from medullary thyroid carcinoma by thyrotropin-releasing hormone: comparison with calcium injection.
    Oishi S; Yamauchi J; Fujimoto Y; Hamasaki S; Umeda T; Sato T
    Acta Endocrinol (Copenh); 1992 Apr; 126(4):325-8. PubMed ID: 1595326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
    Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
    Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of L-dopa with and without inhibition of extra cerebral dopa decarboxylase on gastric acid secretion and gastrin release in man.
    Caldara R; Barbieri C; Piepoli V; Borzio M; Masci E
    Gut; 1985 Oct; 26(10):1014-7. PubMed ID: 4054700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
    Marrinan M; Skrabanek P; Moriarty M; McPartlin J; Powell D
    Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatostatin inhibits the pentagastrin-induced release of serum calcitonin in medullary carcinoma of the thyroid.
    Gordin A; Lamberg BA; Pelkonen R; Almqvist S
    Clin Endocrinol (Oxf); 1978 Apr; 8(4):289-93. PubMed ID: 647984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic evaluation of measurements of carboxyl-terminal flanking peptide (PDN-21) of the human calcitonin gene in human serum.
    Ittner J; Dambacher MA; Born W; Ketelslegers JM; Buysschaert M; Albert PM; Lambert AE; Fischer JA
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1133-7. PubMed ID: 3902867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
    Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No effect of cimetidine on calcitonin secretion from medullary thyroid carcinoma.
    Emmertsen K; Nielsen HE; Mosekilde L; Hansen HH
    Acta Med Scand; 1980; 207(5):367-9. PubMed ID: 7386230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is thyrotropin-releasing hormone as reliable a calcitonin stimulant as pentagastrin in medullary thyroid carcinoma?
    Ahuja S
    Acta Endocrinol (Copenh); 1990 May; 122(5):640-2. PubMed ID: 2112816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pentagastrin, calcium and whisky stimulated serum calcitonin in medullary carcinoma of the thyroid.
    Emmertsen KK; Nielsen HE; Mosekilde L; Hansen HH
    Acta Radiol Oncol; 1980; 19(2):85-9. PubMed ID: 6254339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basal and stimulated release of calcitonin gene-related peptide (CGRP) in patients with medullary thyroid carcinoma.
    Mason RT; Shulkes A; Zajac JD; Fletcher AE; Hardy KJ; Martin TJ
    Clin Endocrinol (Oxf); 1986 Dec; 25(6):675-85. PubMed ID: 3498561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Norepinephrine induced calcitonin secretion in rat medullary thyroid carcinoma 6-23 cells: interaction between intracellular calcium and cAMP.
    Zink-Lorenz A; Komitowska J; Raue F
    Exp Clin Endocrinol Diabetes; 1996; 104(1):43-9. PubMed ID: 8750570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of serum calcitonin by immunometric two-site assays in normal subjects and patients with medullary thyroid carcinoma.
    Zink A; Blind E; Raue F
    Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):831-5. PubMed ID: 1489858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulation test in hereditary MCT.
    Guilloteau D; Perdrisot R; Calmettes C; Baulieu JL; Lecomte P; Kaphan G; Milhaud G; Besnard JC; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1990 Oct; 71(4):1064-7. PubMed ID: 2401708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioactive iodine treatment in medullary thyroid carcinoma.
    Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
    Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical cure of prolactinoma reverses abnormal prolactin repsonse to carbidopa/L-dopa.
    Molitch ME; Goodman RH; Post KD; Biller BJ; Moses AC; King LW; Feldman ZT; Reichlin S
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1118-23. PubMed ID: 7130339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a somatostatin analog (SMS 201-995) in perfusion on basal and pentagastrin-stimulated calcitonin levels in medullary thyroid carcinoma.
    Modigliani E; Chayvialle JA; Cohen R; Perret G; Guliana JM; Vassy R; Roger P; Siame-Mourot C; Bennet M; Bentata-Pessayre M
    Horm Metab Res; 1988 Dec; 20(12):773-5. PubMed ID: 2906036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.